Mohd-Alif W Mohd, Nur-Athirah Adnan, Hanapi Maya Sapira, Tuan Jaffar Tengku Norina, Shatriah Ismail
Ophthalmology, Hospital Raja Perempuan Zainab II, Kota Bharu, MYS.
Ophthalmology and Visual Sciences, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, MYS.
Cureus. 2022 Mar 17;14(3):e23246. doi: 10.7759/cureus.23246. eCollection 2022 Mar.
Central serous chorioretinopathy (CSCR) following coronavirus disease 2019 (COVID-19) infection is rare. We describe an adult patient who survived a COVID-19 infection and received intravenous and oral corticosteroid treatment for three weeks. He presented three weeks post COVID-19 infection with central visual loss in both eyes for six days. Fundus examination showed multiple localized serous retinal detachments in both eyes. Optical coherence tomography (OCT) of the macula confirmed the presence of multiple areas of serous retinal detachment and pigment epithelial detachment. The patient was treated with topical non-steroidal anti-inflammatory eye drops and regained full visual recovery after three months. Corticosteroid treatment for COVID-19 and psychological stress induced by the disease are potential risk factors for the development of CSCR. Physicians should be aware of this side effect, as an early referral to an ophthalmologist for treatment is essential.
2019冠状病毒病（COVID-19）感染后发生的中心性浆液性脉络膜视网膜病变（CSCR）较为罕见。我们描述了一名成年患者，他在COVID-19感染中幸存下来，并接受了为期三周的静脉和口服皮质类固醇治疗。他在COVID-19感染三周后出现双眼中心视力丧失六天。眼底检查显示双眼有多处局限性浆液性视网膜脱离。黄斑区光学相干断层扫描（OCT）证实存在多处浆液性视网膜脱离和色素上皮脱离区域。该患者接受了局部非甾体抗炎眼药水治疗，三个月后视力完全恢复。COVID-19的皮质类固醇治疗以及该疾病引起的心理压力是CSCR发生的潜在危险因素。医生应意识到这种副作用，因为尽早转诊至眼科医生处进行治疗至关重要。
